157 related articles for article (PubMed ID: 12702520)
1. Adjuvant therapy in pancreatic cancer: historical and current perspectives.
Neoptolemos JP; Cunningham D; Friess H; Bassi C; Stocken DD; Tait DM; Dunn JA; Dervenis C; Lacaine F; Hickey H; Raraty MG; Ghaneh P; Büchler MW
Ann Oncol; 2003 May; 14(5):675-92. PubMed ID: 12702520
[TBL] [Abstract][Full Text] [Related]
2. New techniques and agents in the adjuvant therapy of pancreatic cancer.
Raraty MG; Magee CJ; Ghaneh P; Neoptolemos JP
Acta Oncol; 2002; 41(7-8):582-95. PubMed ID: 14651201
[TBL] [Abstract][Full Text] [Related]
3. Conclusions from the European Study Group for Pancreatic Cancer adjuvant trial of chemoradiotherapy and chemotherapy for pancreatic cancer.
Ghaneh P; Neoptolemos JP
Surg Oncol Clin N Am; 2004 Oct; 13(4):567-87, vii-viii. PubMed ID: 15350935
[TBL] [Abstract][Full Text] [Related]
4. Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial.
Neoptolemos JP; Dunn JA; Stocken DD; Almond J; Link K; Beger H; Bassi C; Falconi M; Pederzoli P; Dervenis C; Fernandez-Cruz L; Lacaine F; Pap A; Spooner D; Kerr DJ; Friess H; Büchler MW;
Lancet; 2001 Nov; 358(9293):1576-85. PubMed ID: 11716884
[TBL] [Abstract][Full Text] [Related]
5. A multicenter randomized controlled trial to evaluate the effect of adjuvant cisplatin and 5-fluorouracil therapy after curative resection in cases of pancreatic cancer.
Kosuge T; Kiuchi T; Mukai K; Kakizoe T;
Jpn J Clin Oncol; 2006 Mar; 36(3):159-65. PubMed ID: 16490736
[TBL] [Abstract][Full Text] [Related]
6. Surgery and multimodal treatments in pancreatic cancer--a review on the basis of future multimodal treatment concepts.
Link KH; Leder G; Formentini A; Fortnagel G; Kornmann M; Schatz M; Beger HG
Gan To Kagaku Ryoho; 1999 Jan; 26(1):10-40. PubMed ID: 9987495
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant therapy for pancreatic cancer.
Sultana A; Cox T; Ghaneh P; Neoptolemos JP
Recent Results Cancer Res; 2012; 196():65-88. PubMed ID: 23129367
[TBL] [Abstract][Full Text] [Related]
8. New Techniques and Agents in the Adjuvant Therapy of Pancreatic Cancer.
Raraty MGT; Magee CJ; Ghaneh P; Neoptolemos JP
Acta Oncol; 2002; 41(7-8):582-595. PubMed ID: 28758860
[TBL] [Abstract][Full Text] [Related]
9. Chemotherapy for pancreatic cancer.
Springfeld C; Jäger D; Büchler MW; Strobel O; Hackert T; Palmer DH; Neoptolemos JP
Presse Med; 2019 Mar; 48(3 Pt 2):e159-e174. PubMed ID: 30879894
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant therapy for pancreatic cancer.
Ghaneh P; Slavin J; Sutton R; Neoptolemos JP
Swiss Surg; 2000; 6(5):289-95. PubMed ID: 11077498
[TBL] [Abstract][Full Text] [Related]
11. ESPAC-1 trial progress report: the European randomized adjuvant study comparing radiochemotherapy, 6 months chemotherapy and combination therapy versus observation in pancreatic cancer.
Neoptolemos JP; Kerr DJ; Beger H; Link K; Pederzoli P; Bassi C; Dervenis C; Fernandez-Cruz L; Laçaine F; Friess H; Büchler M
Digestion; 1997; 58(6):570-7. PubMed ID: 9438604
[TBL] [Abstract][Full Text] [Related]
12. [Clinical study of the month. Adjuvant radio-chemotherapy and chemotherapy following curative resection of pancreatic cancer: results of the randomized trial ESPAC-1].
Polus M; Jerusalem G; Sautois B; Silvestre RM; Collette MY; Closon MT; Fillet G
Rev Med Liege; 2002 Feb; 57(2):119-22. PubMed ID: 11942178
[TBL] [Abstract][Full Text] [Related]
13. Evaluating the Impact of ESPAC-1 on Shifting the Paradigm of Pancreatic Cancer Treatment.
Winer LK; Cortez AR; Ahmad SA; Wima K; Olowokure O; Latif T; Kharofa J; Patel SH
J Surg Res; 2021 Mar; 259():442-450. PubMed ID: 33059910
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant therapy in pancreatic cancer.
Thomas A; Dajani K; Neoptolemos JP; Ghaneh P
Dig Dis; 2010; 28(4-5):684-92. PubMed ID: 21088421
[TBL] [Abstract][Full Text] [Related]
15. The role of adjuvant therapy for pancreatic cancer.
Magee CJ; Ghaneh P; Hartley M; Sutton R; Neoptolemos JP
Expert Opin Investig Drugs; 2002 Jan; 11(1):87-107. PubMed ID: 11772324
[TBL] [Abstract][Full Text] [Related]
16. Resection and radiochemotherapy of pancreatic cancer--the future?
Link KH; Formentini A; Leder G; Fortnagel G; Sartori N; Schatz M; Beger HG
Langenbecks Arch Surg; 1998 Apr; 383(2):134-44. PubMed ID: 9641886
[TBL] [Abstract][Full Text] [Related]
17. Longitudinal quality of life data can provide insights on the impact of adjuvant treatment for pancreatic cancer-Subset analysis of the ESPAC-1 data.
Carter R; Stocken DD; Ghaneh P; Bramhall SR; Olah A; Kelemen D; Bassi C; Friess H; Dervenis C; Spry N; Büchler MW; Neoptolemos JP;
Int J Cancer; 2009 Jun; 124(12):2960-5. PubMed ID: 19330830
[TBL] [Abstract][Full Text] [Related]
18. The case for adjuvant chemotherapy in pancreatic cancer.
Ghaneh P; Sultana A; Shore S; Stocken D; Neoptolemos J
Best Pract Res Clin Gastroenterol; 2006 Apr; 20(2):383-401. PubMed ID: 16549334
[TBL] [Abstract][Full Text] [Related]
19. Progress report. A randomized multicenter European study comparing adjuvant radiotherapy, 6-mo chemotherapy, and combination therapy vs no-adjuvant treatment in resectable pancreatic cancer (ESPAC-1).
Neoptolemos JP; Baker P; Beger H; Link K; Pederzoli P; Bassi C; Dervenis C; Friess H; Büchler M
Int J Pancreatol; 1997 Apr; 21(2):97-104. PubMed ID: 9209950
[TBL] [Abstract][Full Text] [Related]
20. Overall survival of patients with recurrent pancreatic cancer treated with systemic therapy: a retrospective study.
Gbolahan OB; Tong Y; Sehdev A; O'Neil B; Shahda S
BMC Cancer; 2019 May; 19(1):468. PubMed ID: 31101022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
